Trial intelligence / Profile preview

CARIN: Capecitabine and Bevacizumab +/- Vinorelbine in Metastatic Breast Cancer

NCT00868634Phase 3Completed

Sponsor
iOMEDICO
Start
Feb 2009
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of vinorelbine in breast cancer, sponsored by iOMEDICO. Started Feb 2009; status: completed.

02

Drugs

vinorelbine
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00868634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00868634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call